We have observed
2 EP applications
Solveig Magdalena Boije-Backman
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 24, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
DIAGNOSTIC ASSAY FOR TYPE 1 DIABETES
Multi-CBV vaccine for preventing or treating type 1 diabetes